-
Behavioral Medicine & Nephrology
A software platform to monitor and improve patients' adherence to medications and treatments.
-
Gastroenterology
Plasma Proteomic Response Signature of Children Receiving Infliximab for Crohn’s Disease
-
Drug Delivery
A prototype of a self-contained morcellator for preparing medication
for feeding tube delivery
-
Dermatology
A newly established link between the mechanistic role of thrombin and fibrinogen and their contribution to AD provides a novel mechanism for oral treatment.
-
Allergy
Recent studies have linked the importance of AHR as a regulator of
EoE pathogenesis and the potential of AHR activation by small molecules as EoE therapy.
-
Gastroenterology
Oncostatin M biomarkers are associated with non-response to Infliximab therapy
-
Genetic Diseases
Optimal dosing regimen for treating seizures and self-aggressive behavior
-
Oncology
Our proprietary inhibitor binds to VAV3 thereby inhibiting the activation of RAC downstream of several oncogenes.
-
Immunology
Perforin inhibition during vaccination can improve vaccine success
against a variety of infections and diseases for which sufficiently
efficacious immune response has proven difficult
-
Gene and Cell therapy
Organoids provide an unprecedented opportunity to study human organ development and physiology, and investigate the cause of disease.